Sign in

CIK 0001754068

  • Non-accelerated filer
  • Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831971007
Phone
+1 650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. 4 Open-market sale Chief Accounting Officer sold 554 shares at $0.55 ($304)
  2. 4 Open-market sale Sinha Vikas sold 3,186 shares at $0.55 ($1,748)
  3. 4 Open-market sale General Counsel sold 432 shares at $0.55 ($237)
  4. 4 Open-market sale Chief Executive Officer sold 8,706 shares at $0.55 ($4,775)
  5. 4 Open-market sale Chief Executive Officer sold 10,609 shares at $0.86 ($9,176)
  6. 4 Open-market sale General Counsel sold 2,272 shares at $0.86 ($1,965)
  7. 4 Open-market sale Chief Accounting Officer sold 1,655 shares at $0.86 ($1,431)
  8. 4 Open-market sale Sinha Vikas sold 5,136 shares at $0.86 ($4,442)
  9. 4 Open-market sale Sinha Vikas sold 3,428 shares at an average $0.77 ($2,649)
  10. 4 Open-market sale Chief Executive Officer sold 9,752 shares at $0.78 ($7,597)
  11. 4 Open-market sale Chief Accounting Officer sold 965 shares at an average $0.77 ($746)
  12. 4 Open-market sale General Counsel sold 1,401 shares at an average $0.77 ($1,083)
  13. 4 Open-market sale Sinha Vikas sold 940 shares at $0.81 ($766)
  14. 4 Open-market sale General Counsel sold 377 shares at $0.81 ($307)
  15. 4 Open-market sale Chief Executive Officer sold 1,493 shares at $0.81 ($1,216)
  16. 4 Open-market sale Chief Accounting Officer sold 301 shares at $0.81 ($245)
  17. 4 Open-market sale Chief Executive Officer sold 5,390 shares at $0.74 ($3,996)
  18. 4 Open-market sale General Counsel sold 422 shares at $0.76 ($321)
  19. 4 Open-market sale Chief Accounting Officer sold 544 shares at $0.76 ($413)
  20. 4 Open-market sale Sinha Vikas sold 3,159 shares at $0.76 ($2,399)

Page 4 of 19 · 363 filings